Europe PMC
metadata only
An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice
abstract available
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Disruption of endothelial stability directly impacts vascular neighboring cells in Hereditary Hemorrhagic Telangiectasia#266270
- A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia#1281673
- CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness#866650
- Functional alterations involved in increased bleeding in hereditary hemorrhagic telangiectasia mouse models#337360
- Challenges and Future Trends in Large Vessel Vasculitis.#308803
Record · ID 1250597
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive